Showing 374 results

Filters Content type: News, Editors' picks Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

Side effects

PrEP in pregnancy: safe, but many unanswered questions

News
7 February 2020
PrEP science

HIV PrEP could also lead to big reductions in gonorrhoea, Dutch study finds

News
23 January 2020
PrEP policies & guidelines

Truvada, not Descovy, should be the first choice for PrEP, US experts say

News
14 January 2020
Bad science & bogus treatments

Facebook disables some misleading ads on HIV prevention drugs, responding to growing outcry

Editor's pick
Washington Post
2 January 2020
PrEP science

Facebook ads push misinformation about HIV prevention drugs, LGBT activists say, ‘harming public health’

Editor's pick
Washington Post
10 December 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
PrEP science

Serosorting between gay men may be in decline as ‘PrEP sorting’ rises, Canadian study finds

News
20 November 2019
PrEP science

How do we deal with apparent cases of PrEP failure?

News
15 November 2019
PrEP science

96-week results of DISCOVER PrEP trial presented at European AIDS Conference

News
14 November 2019
PrEP programmes & uptake

French study finds one in six stops PrEP within 12 months, one in three after 30 months

News
11 November 2019
PrEP science

Descovy for PrEP Continues to Be Noninferior to Truvada, According to 96 Week Data

Editor's pick
Monthly Prescribing Reference
8 November 2019
PrEP science

Future PrEP Drugs, Delivery Methods, Technologies Target Adherence Issue

Editor's pick
American Journal of Managed Care
1 November 2019
PrEP science

Where Were the Women? Gender Parity in Clinical Trials

Editor's pick
New England Journal of Medicine (free registration required)
31 October 2019
PrEP science

Switching to TAF-based PrEP improves kidney and bone markers – but does it raise cardiovascular risk?

News
15 October 2019
PrEP policies & guidelines

US FDA approves TAF-based PrEP for many people at risk for HIV

News
7 October 2019
PrEP science

Evaluating Microarray Patches for Long-Acting PrEP and Contraceptives

Editor's pick
Contagion Live
3 October 2019
Injectable & long-acting HIV treatment

HIV implant targets disease for up to a year

Editor's pick
The Engineer
26 September 2019
PrEP science

Long-acting injectable multi-drug implant shows promise for HIV prevention and treatment

Editor's pick
EurekAlert
23 September 2019
PrEP programmes & uptake

PrEP is reducing HIV diagnoses in US cities, independently of the effect of treatment

News
12 September 2019
PrEP policies & guidelines

A New Oral PrEP Strategy Is On the Horizon, But Who’s Going to Get It?

Editor's pick
AVAC
29 August 2019
PrEP science

Gilead's Descovy AdCom gets 'controversial' as panelists split over use in women

Editor's pick
Fierce Pharma
8 August 2019
PrEP science

Does Descovy Really Work Better Than Truvada for PrEP? One Researcher Raises Questions About the DISCOVER Trial Results

Editor's pick
TheBodyPro
3 August 2019